Advertisement
Advertisement
U.S. markets open in 5 hours 39 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Vascular Biogenics Ltd. (VBLT)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
0.1530+0.0050 (+3.38%)
At close: 04:00PM EST
0.1600 +0.01 (+4.58%)
After hours: 07:50PM EST
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 11/28/2022
Current
9/30/20226/30/202212/31/20219/30/2021
Market Cap (intraday)
10.32M10.83M111.65M136.57M128.27M
Enterprise Value
-16.32M-21.46M69.35M88.52M73.90M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/A
Price/Sales (ttm)
13.3120.36168.09151.23143.66
Price/Book (mrq)
0.410.322.612.692.30
Enterprise Value/Revenue
-19.11-44.611.08k451.64371.34
Enterprise Value/EBITDA
0.452.45-7.67-10.10-11.97

Trading Information

Stock Price History

Beta (5Y Monthly) 0.64
52-Week Change 3-93.62%
S&P500 52-Week Change 3-11.84%
52 Week High 32.3800
52 Week Low 30.1080
50-Day Moving Average 30.1430
200-Day Moving Average 30.9342

Share Statistics

Avg Vol (3 month) 31.4M
Avg Vol (10 day) 31.26M
Shares Outstanding 569.75M
Implied Shares Outstanding 6N/A
Float 846.83M
% Held by Insiders 122.48%
% Held by Institutions 117.55%
Shares Short (Nov 14, 2022) 4191.28k
Short Ratio (Nov 14, 2022) 40.23
Short % of Float (Nov 14, 2022) 40.33%
Short % of Shares Outstanding (Nov 14, 2022) 40.27%
Shares Short (prior month Oct 13, 2022) 4158.22k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Sep 29, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-4,515.81%

Management Effectiveness

Return on Assets (ttm)-49.87%
Return on Equity (ttm)-102.32%

Income Statement

Revenue (ttm)854k
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)141.70%
Gross Profit (ttm)403k
EBITDA -37.17M
Net Income Avi to Common (ttm)-38.14M
Diluted EPS (ttm)-0.4690
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)27.38M
Total Cash Per Share (mrq)0.39
Total Debt (mrq)731k
Total Debt/Equity (mrq)2.89
Current Ratio (mrq)2.82
Book Value Per Share (mrq)0.36

Cash Flow Statement

Operating Cash Flow (ttm)-31.51M
Levered Free Cash Flow (ttm)-18.61M
Advertisement
Advertisement